المؤلفون: Gultekin O; Department of Medical Pharmacology, School of Medicine, Marmara University, Istanbul, Turkey., Aydin V; Department of Medical Pharmacology, International School of Medicine, Istanbul Medipol University, Istanbul, Turkey., Bayram D; Department of Pharmacology, School of Pharmacy, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey., Atac O; Department of Public Health, International School of Medicine, Istanbul Medipol University, Istanbul, Turkey.; Department of Health Management and Policy, College of Public Health, University of Kentucky, Lexington, KY, USA., Akici A; Department of Medical Pharmacology, School of Medicine, Marmara University, Istanbul, Turkey.; Department of Medical Pharmacology, School of Medicine, Eastern Mediterranean University, Famagusta, North Cyprus.

المصدر: Primary health care research & development [Prim Health Care Res Dev] 2024 Sep 20; Vol. 25, pp. e40. Date of Electronic Publication: 2024 Sep 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Cambridge University Press Country of Publication: England NLM ID: 100897390 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-1128 (Electronic) Linking ISSN: 14634236 NLM ISO Abbreviation: Prim Health Care Res Dev Subsets: MEDLINE

مواضيع طبية MeSH: Drugs, Generic*/therapeutic use , Drugs, Generic*/economics , Antidepressive Agents*/therapeutic use , Antidepressive Agents*/economics , Primary Health Care*/statistics & numerical data , Primary Health Care*/economics, Humans ; Female ; Cross-Sectional Studies ; Male ; Middle Aged ; Adult ; Aged ; Turkey ; Economics, Pharmaceutical ; Practice Patterns, Physicians'/statistics & numerical data ; Depression/drug therapy ; Drug Costs/statistics & numerical data

المؤلفون: Ishimura A; Division of Practical Pharmacy, Nihon Pharmaceutical University, Saitama, Japan., Ogawa C; Department of Pharmacy, NHO Tokyo Medical Center, Tokyo, Japan., Yatabe M; Department of Pharmacy, NHO Saitama Hospital, Saitama, Japan., Tani K; Department of Pharmacy, NHO Tokyo Medical Center, Tokyo, Japan., Inoue M; Department of Physical Chemistry, Hoshi University, Tokyo, Japan.

المصدر: Drug discoveries & therapeutics [Drug Discov Ther] 2024 Sep 19; Vol. 18 (4), pp. 265-268. Date of Electronic Publication: 2024 Aug 29.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Shandong University China-Japan Cooperation Center for Drug Discovery & Screen Country of Publication: Japan NLM ID: 101493809 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1881-784X (Electronic) Linking ISSN: 18817831 NLM ISO Abbreviation: Drug Discov Ther Subsets: MEDLINE

مواضيع طبية MeSH: Ointments* , Drugs, Generic*/administration & dosage , Drugs, Generic*/chemistry , Rheology*, Viscosity ; Humans ; Injections ; Elasticity ; Drug Compounding ; Chemistry, Pharmaceutical

المؤلفون: Singh GJP; BBSG Pharm Associates, LLC, 7641 Summer Day Drive, Corona, California 92883, United States., Hickey AJ; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, 125 Mason Farm Road, Chapel Hill, North Carolina 27599, United States.

المصدر: Molecular pharmaceutics [Mol Pharm] 2024 Sep 02; Vol. 21 (9), pp. 4191-4198. Date of Electronic Publication: 2024 Aug 12.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101197791 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1543-8392 (Electronic) Linking ISSN: 15438384 NLM ISO Abbreviation: Mol Pharm Subsets: MEDLINE

مواضيع طبية MeSH: Therapeutic Equivalency* , Drugs, Generic*/pharmacokinetics , Drugs, Generic*/administration & dosage, Administration, Inhalation ; Humans ; Biological Availability ; United States ; United States Food and Drug Administration ; Drug Approval

المؤلفون: Liu Z; Phase I Clinical Trial Laboratory, Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China., Xue J; Clinical Research Center, Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Nanjing, China., Deng Q; Phase I Clinical Trial Laboratory, Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China., Wang Y; Phase I Clinical Trial Laboratory, Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China., Zhang L; Lung Disease Center, Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China., Liu L; The Clinical Trial Quality Control Center, Ansiterui Medical Technology Consulting Co., Ltd., Changchun, China., Xiao N; Clinical Research Center, Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Nanjing, China., Chang T; Phase I Clinical Trial Laboratory, Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China., Cui Y; Phase I Clinical Trial Laboratory, Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China., Cheng Y; Phase I Clinical Trial Laboratory, Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China., Liu G; Phase I Clinical Trial Laboratory, Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China., Wang W; Phase I Clinical Trial Laboratory, Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China., Zhou Y; Phase I Clinical Trial Laboratory, Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China., Yang W; Phase I Clinical Trial Laboratory, Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China., Qu X; Phase I Clinical Trial Laboratory, Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China., Chen J; Phase I Clinical Trial Laboratory, Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China., Zhao Y; Center for Pathogen Biology and Infectious Diseases, Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, The First Hospital of Jilin University, Changchun, China., Wang Z; Northeast Asia Research Institute of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China. zeyu781022@163.com., Yang H; Phase I Clinical Trial Laboratory, Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China. haimiaoyang@outlook.com.

المصدر: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2024 Sep; Vol. 397 (9), pp. 7051-7060. Date of Electronic Publication: 2024 Apr 21.

نوع المنشور: Journal Article; Clinical Trial, Phase I; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0326264 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1912 (Electronic) Linking ISSN: 00281298 NLM ISO Abbreviation: Naunyn Schmiedebergs Arch Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Therapeutic Equivalency* , Lurasidone Hydrochloride*/pharmacokinetics , Lurasidone Hydrochloride*/administration & dosage , Lurasidone Hydrochloride*/adverse effects , Drugs, Generic*/pharmacokinetics , Drugs, Generic*/adverse effects , Drugs, Generic*/administration & dosage , Cross-Over Studies* , Antipsychotic Agents*/pharmacokinetics , Antipsychotic Agents*/adverse effects , Antipsychotic Agents*/administration & dosage , Antipsychotic Agents*/blood, Humans ; Male ; Adult ; Young Adult ; Female ; Healthy Volunteers ; Asian People ; Area Under Curve ; East Asian People

المؤلفون: Lourenço D; Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal., Miranda M; Coimbra Chemistry Center, Department of Chemistry, University of Coimbra, 3004-535 Coimbra, Portugal; Coimbra Chemistry Centre, Institute of Molecular Sciences-IMS, Department of Chemistry, University of Coimbra, 3004-535 Coimbra, Portugal. Electronic address: mimiranda@live.com.pt., Sousa JJ; Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal; Coimbra Chemistry Centre, Institute of Molecular Sciences-IMS, Department of Chemistry, University of Coimbra, 3004-535 Coimbra, Portugal., Vitorino C; Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal; Coimbra Chemistry Centre, Institute of Molecular Sciences-IMS, Department of Chemistry, University of Coimbra, 3004-535 Coimbra, Portugal. Electronic address: csvitorino@ff.uc.pt.

المصدر: International journal of pharmaceutics [Int J Pharm] 2024 Aug 15; Vol. 661, pp. 124398. Date of Electronic Publication: 2024 Jul 02.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7804127 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3476 (Electronic) Linking ISSN: 03785173 NLM ISO Abbreviation: Int J Pharm Subsets: MEDLINE

مواضيع طبية MeSH: Therapeutic Equivalency* , Drugs, Generic*/pharmacokinetics , Drugs, Generic*/administration & dosage , Administration, Topical*, Humans ; Animals ; United States Food and Drug Administration ; United States

المؤلفون: da Silva TM; Clinical Research Unit, Adium S.A., São Paulo, São Paulo, Brazil., Davanço MG; Clinical Research Unit, Adium S.A., São Paulo, São Paulo, Brazil., Meulman J; Clinical Research Unit, Adium S.A., São Paulo, São Paulo, Brazil., Vianna DRB; Clinical Research Unit, Adium S.A., São Paulo, São Paulo, Brazil., Costa F; Corporate Department of Clinical Studies, Adium S.A. Headquarters, Buenos Aires, Buenos Aires, Argentina., Pacheco FBC; Bioequivalence Unit, Centro Avançado de Estudos e Pesquisas Ltd., Campinas, Brazil., Carandina SAC; Bioequivalence Unit, Centro Avançado de Estudos e Pesquisas Ltd., Campinas, Brazil., Issa E; Medical Department, Adium S.A., São Paulo, São Paulo, Brazil., Vespasiano CFP; Clinical Research Unit, Adium S.A., São Paulo, São Paulo, Brazil.

المصدر: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2024 Aug; Vol. 13 (8), pp. 907-914. Date of Electronic Publication: 2024 May 08.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2160-7648 (Electronic) Linking ISSN: 2160763X NLM ISO Abbreviation: Clin Pharmacol Drug Dev Subsets: MEDLINE

مواضيع طبية MeSH: Tramadol*/pharmacokinetics , Tramadol*/administration & dosage , Diclofenac*/pharmacokinetics , Diclofenac*/administration & dosage , Cross-Over Studies* , Therapeutic Equivalency* , Drug Combinations* , Drugs, Generic*/pharmacokinetics , Drugs, Generic*/administration & dosage , Drugs, Generic*/adverse effects , Biological Availability* , Acute Pain*/drug therapy , Analgesics, Opioid*/pharmacokinetics , Analgesics, Opioid*/administration & dosage , Area Under Curve*, Humans ; Male ; Female ; Adult ; Young Adult ; Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics ; Anti-Inflammatory Agents, Non-Steroidal/administration & dosage ; Middle Aged ; Brazil ; Pain Management/methods ; Healthy Volunteers ; Tandem Mass Spectrometry

المؤلفون: Zhang L; Phase 1 Clinical Trial Center, Deyang People's Hospital, Deyang, Sichuan, People's Republic of China., Li M; Phase 1 Clinical Trial Center, Deyang People's Hospital, Deyang, Sichuan, People's Republic of China., Fan L; Phase 1 Clinical Trial Center, Deyang People's Hospital, Deyang, Sichuan, People's Republic of China., Liu F; Phase 1 Clinical Trial Center, Deyang People's Hospital, Deyang, Sichuan, People's Republic of China., Zhang P; Phase 1 Clinical Trial Center, Deyang People's Hospital, Deyang, Sichuan, People's Republic of China., Huang Q; Phase 1 Clinical Trial Center, Deyang People's Hospital, Deyang, Sichuan, People's Republic of China., Mai G; Phase 1 Clinical Trial Center, Deyang People's Hospital, Deyang, Sichuan, People's Republic of China., Shentu J; Phase 1 Clinical Trial Center, Deyang People's Hospital, Deyang, Sichuan, People's Republic of China.; Research Center for Clinical Pharmacy, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of China.

المصدر: Drug design, development and therapy [Drug Des Devel Ther] 2024 Jul 10; Vol. 18, pp. 2891-2904. Date of Electronic Publication: 2024 Jul 10 (Print Publication: 2024).

نوع المنشور: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Dove Press Limited Country of Publication: New Zealand NLM ID: 101475745 Publication Model: eCollection Cited Medium: Internet ISSN: 1177-8881 (Electronic) Linking ISSN: 11778881 NLM ISO Abbreviation: Drug Des Devel Ther Subsets: MEDLINE

مواضيع طبية MeSH: Cross-Over Studies* , Drugs, Generic*/pharmacokinetics , Drugs, Generic*/administration & dosage , Drugs, Generic*/adverse effects , Estradiol*/pharmacokinetics , Estradiol*/administration & dosage , Estradiol*/blood , Estradiol*/analogs & derivatives , Postmenopause* , Tablets* , Therapeutic Equivalency*, Female ; Humans ; Middle Aged ; Administration, Oral ; Asian People ; China ; East Asian People ; Healthy Volunteers

المؤلفون: Krabel BJ; Elanco Animal Health, Greenfield, Indiana, USA., Foust LB; Elanco Animal Health, Greenfield, Indiana, USA., Fuller GB; Elanco Animal Health, Greenfield, Indiana, USA., Hunter RP; One Medicine Consulting, Olathe, Kansas, USA.

المصدر: Journal of veterinary pharmacology and therapeutics [J Vet Pharmacol Ther] 2024 Jul; Vol. 47 (4), pp. 288-293. Date of Electronic Publication: 2024 Feb 26.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 7910920 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2885 (Electronic) Linking ISSN: 01407783 NLM ISO Abbreviation: J Vet Pharmacol Ther Subsets: MEDLINE

مواضيع طبية MeSH: Monensin*/pharmacokinetics , Monensin*/chemistry , Monensin*/administration & dosage , Solubility* , Drugs, Generic*/pharmacokinetics , Drugs, Generic*/chemistry, Therapeutic Equivalency ; Animals

المؤلفون: Glerum PJ; Medicines Evaluation Board, Utrecht, The Netherlands.; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre+, Maastricht, The Netherlands., Yamada WM; Laboratory of Applied Pharmacokinetics and Bioinformatics, Children's Hospital Los Angeles, University of Southern California, Los Angeles, California, USA., Neely MN; Laboratory of Applied Pharmacokinetics and Bioinformatics, Children's Hospital Los Angeles, University of Southern California, Los Angeles, California, USA., Burger DM; Department of Pharmacy, Radboud University Medical Centre, Nijmegen, The Netherlands., Maliepaard M; Medicines Evaluation Board, Utrecht, The Netherlands.; Department of Pharmacology and Toxicology, Radboud University Medical Centre, Nijmegen, The Netherlands., Neef C; Department of Clinical Pharmacy and Toxicology, CARIM, Maastricht University, Maastricht, The Netherlands.

المصدر: British journal of clinical pharmacology [Br J Clin Pharmacol] 2024 Jul; Vol. 90 (7), pp. 1576-1585. Date of Electronic Publication: 2023 Feb 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Therapeutic Equivalency* , Drugs, Generic*/pharmacokinetics , Drugs, Generic*/administration & dosage , Gabapentin*/pharmacokinetics , Gabapentin*/administration & dosage , Biological Availability* , Models, Biological* , Amines*/pharmacokinetics , Amines*/administration & dosage , Computer Simulation*, Humans ; Adult ; Cyclohexanecarboxylic Acids/pharmacokinetics ; Cyclohexanecarboxylic Acids/administration & dosage ; Male ; gamma-Aminobutyric Acid/pharmacokinetics ; gamma-Aminobutyric Acid/administration & dosage ; Female

المؤلفون: Hernandez I; Skaggs School of Pharmacy, University of California San Diego., Sullivan SD; The CHOICE Institute, School of Pharmacy, University of Washington, Seattle., Hansen RN; The CHOICE Institute, School of Pharmacy, University of Washington, Seattle., Fendrick AM; Department of Internal Medicine, University of Michigan, Ann Arbor.

المصدر: Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2024 Jul; Vol. 30 (7), pp. 719-727.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Academy of Managed Care Pharmacy Country of Publication: United States NLM ID: 101644425 Publication Model: Print Cited Medium: Internet ISSN: 2376-1032 (Electronic) Linking ISSN: 23760540 NLM ISO Abbreviation: J Manag Care Spec Pharm Subsets: MEDLINE

مواضيع طبية MeSH: Drugs, Generic*/economics , Drugs, Generic*/supply & distribution , Drug Industry*/economics, United States ; Humans ; Drug Costs ; Cost Control ; Pharmaceutical Preparations/supply & distribution ; Pharmaceutical Preparations/economics ; Value-Based Purchasing ; Reimbursement Mechanisms